There are 10 papers on des-gamma-carboxy prothrombin in aging research: 1 trial and 7 observational studies in people, 2 reviews.
10 papers study it1 finding
See all 10 papers on des-gamma-carboxy prothrombin
“a doubling of des-γ-carboxy prothrombin concentration was associated with a 1.53 (95% confidence interval, 1.09-2.13; P=0.008) higher risk of incident ischemic cardiovascular disease.”
- Human trial1
- Humans7
Associations
1Incident ischemic cardiovascular disease
upin humans1
1 study
Incident ischemic cardiovascular disease
upin humans1
Des-gamma-carboxy prothrombin is associated with incident ischemic cardiovascular disease in humans (1.53-fold higher risk per doubling of concentration; 95% CI 1.09–2.13).
“a doubling of des-γ-carboxy prothrombin concentration was associated with a 1.53 (95% confidence interval, 1.09-2.13; P=0.008) higher risk of incident ischemic cardiovascular disease.”
HumansInitially free of cardiovascular disease; adjusted for traditional cardiovascular risk factors and measures of vitamin K intake11.0 yearsn = 709
Arteriosclerosis, thrombosis, and vascular biology
Latest
8 papers in 12 monthsTechnology in Cancer Research & Treatment
Screening of Hepatocellular Carcinoma in Hepatic Cirrhosis Patients by a Novel Blood-Based Multi-Omics Test
Cohort study of 650 peopleHepatocellular carcinoma
Molecular Biomedicine
Development and validation of a high-confidence diagnostic model integrating ctDNA methylation and serum biomarkers for early-stage hepatocellular carcinoma detection
Cohort study of 1,692 peopleHepatocellular carcinoma
Clinical and Molecular Hepatology
GAFAD: A liquid chromatography-tandem mass spectrometry-based model for early hepatocellular carcinoma detection beyond GALAD's limitations
Cohort study in peopleHepatocellular carcinoma
Clinics
Validation of the GALAD model for diagnosing HBV-related hepatocellular carcinoma in Chinese patients
Cohort study of 247 peopleBiomarkers
World Journal of Gastroenterology
Refining early detection of hepatocellular carcinoma: The promise of the GALAD score
CommentaryHepatocellular carcinoma
Gastroenterology
Utility of Serum Biomarkers in Addition to Ultrasound for Early Detection of Hepatocellular Carcinoma in High-Risk Patients: A Randomized Controlled Trial
Randomized trial in 1,208 peopleHepatocellular carcinoma
BMC Cancer
A preliminary study on the reference intervals of serum tumor marker in apparently healthy elderly population in southwestern China using real-world data
Cross-sectional study of 35,635 peopleBiomarkers
Arteriosclerosis, Thrombosis, and Vascular Biology
Vitamin K-Dependent Protein Activity and Incident Ischemic Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis
Cohort study of 709 peopleCardiovascular disease